Tag Archives: During

J&J, Bayer’s Xarelto scores FDA nod to treat acutely ill patients during and after hospitalization

Johnson & Johnson and Bayer’s Xarelto, once king of the warfarin alternative market, is now chasing chasing Pfizer and Bristol-Myers Squibb’s Eliquis. But with a new approved indication in the books—its eighth—it’s not backing down. The FDA on Monday approved Xarelto to help prevent blood clots for acutely ill patients without a high risk of bleeding during… Read More »

What should people avoid inhaling during mysterious lung disease outbreak? Health officials disagree

Health officials are warning consumers about a mysterious lung disease that has sickened hundreds and killed at least three people. What to avoid? That’s where they disagree. Federal health officials are reviewing 450 possible cases linked to vaping across 33 states and one territory. At least three people have died from the illness. It’s too… Read More »

Opioid Exposure During Pregnancy, Long-Term Effects on Children’s Development

According to a recent analysis of national data by the Centers for Disease Control, the number of pregnant women with opioid use disorder (as documented at the time of delivery) more than quadrupled from 1999 through 2014.  Studies of opioid exposure in pregnancy suggest increased risk for adverse pregnancy outcomes including stillbirth, low birth weight,… Read More »

New Research from the CWMH: Prenatal Supplement Containing Folate May Reduce Depressive Symptoms During Pregnancy

While there is research to support the reproductive safety of many antidepressants, many woman and their providers ask about alternatives to traditional antidepressants in women who are pregnant or planning to conceive.  In a recent study, Dr. Marlene Freeman and colleagues at the Center for Women’s Mental Health explored the use of a folate-based preparation… Read More »